FI20100211A0 - Menetelmä ateroskleroosialttiuden geneettiseksi diagnosoimiseksi - Google Patents

Menetelmä ateroskleroosialttiuden geneettiseksi diagnosoimiseksi

Info

Publication number
FI20100211A0
FI20100211A0 FI20100211A FI20100211A FI20100211A0 FI 20100211 A0 FI20100211 A0 FI 20100211A0 FI 20100211 A FI20100211 A FI 20100211A FI 20100211 A FI20100211 A FI 20100211A FI 20100211 A0 FI20100211 A0 FI 20100211A0
Authority
FI
Finland
Prior art keywords
atherosclerosis
susceptibility
genetic diagnosis
genetic
diagnosis
Prior art date
Application number
FI20100211A
Other languages
English (en)
Swedish (sv)
Inventor
Igor A Sobenin
Alexander N Orekhov
Jukka Salonen
Original Assignee
Mas Metabolic Analytical Servi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mas Metabolic Analytical Servi filed Critical Mas Metabolic Analytical Servi
Priority to FI20100211A priority Critical patent/FI20100211A0/fi
Publication of FI20100211A0 publication Critical patent/FI20100211A0/fi
Priority to EP11783142.0A priority patent/EP2572002A4/en
Priority to US13/698,535 priority patent/US20130136726A1/en
Priority to PCT/FI2011/050459 priority patent/WO2011144818A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/415—Cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI20100211A 2010-05-19 2010-05-19 Menetelmä ateroskleroosialttiuden geneettiseksi diagnosoimiseksi FI20100211A0 (fi)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FI20100211A FI20100211A0 (fi) 2010-05-19 2010-05-19 Menetelmä ateroskleroosialttiuden geneettiseksi diagnosoimiseksi
EP11783142.0A EP2572002A4 (en) 2010-05-19 2011-05-19 METHOD OF DETECTING A PREDISPOSITION TO ATHEROSCLEROSIS, CORONAROPATHY AND ASSOCIATED STATES
US13/698,535 US20130136726A1 (en) 2010-05-19 2011-05-19 Method for detection of predisposition to atherosclerosis, coronary heart disease and related conditions
PCT/FI2011/050459 WO2011144818A1 (en) 2010-05-19 2011-05-19 Method for detection of predisposition to atherosclerosis, coronary heart disease and related conditions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20100211A FI20100211A0 (fi) 2010-05-19 2010-05-19 Menetelmä ateroskleroosialttiuden geneettiseksi diagnosoimiseksi

Publications (1)

Publication Number Publication Date
FI20100211A0 true FI20100211A0 (fi) 2010-05-19

Family

ID=42234250

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20100211A FI20100211A0 (fi) 2010-05-19 2010-05-19 Menetelmä ateroskleroosialttiuden geneettiseksi diagnosoimiseksi

Country Status (4)

Country Link
US (1) US20130136726A1 (fi)
EP (1) EP2572002A4 (fi)
FI (1) FI20100211A0 (fi)
WO (1) WO2011144818A1 (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9250172B2 (en) 2012-09-21 2016-02-02 Ethicon Endo-Surgery, Inc. Systems and methods for predicting metabolic and bariatric surgery outcomes
WO2014047432A1 (en) 2012-09-21 2014-03-27 Ethicon Endo-Surgery, Inc. Clinical predictors of weight loss
US10242756B2 (en) 2012-09-21 2019-03-26 Ethicon Endo-Surgery, Inc. Systems and methods for predicting metabolic and bariatric surgery outcomes
CN104050344A (zh) * 2013-09-30 2014-09-17 西安时代基因健康科技有限公司 冠心病的表征参数的获取方法
WO2015086913A1 (en) 2013-12-12 2015-06-18 Mas-Metabolic Analytical Services Oy Methods for detection of the risk of obesity, the metabolic syndrome and diabetes
JP6548115B2 (ja) * 2015-07-15 2019-07-24 国立大学法人名古屋大学 動脈硬化症マーカー及びその利用
RU2600023C1 (ru) * 2015-12-29 2016-10-20 Федеральное государственное бюджетное учреждение "Российский кардиологический научно-производственный комплекс" Министерства здравоохранения России (ФГБУ "РКНПК" МЗ РФ) Способ определения степени гетероплазмии мутаций митохондриального генома
CN105713972A (zh) * 2016-03-16 2016-06-29 上海中医药大学 miRNA在制备药物性心脏病生物标志物中的用途
WO2018200489A1 (en) * 2017-04-25 2018-11-01 The Brigham And Women’S Hospital, Inc. Il-8, il-6, il-1b and tet2 and dnmt3a in atherosclerosis
EP3578671A1 (en) * 2018-06-05 2019-12-11 Universitat Autònoma De Barcelona Method for evaluating risk of cardiovascular disease
EP4048297A4 (en) * 2019-10-24 2023-11-15 Imel Biotherapeutics, Inc. METHODS FOR DETECTING MACRO-HETEROPLASMY AND MICRO-HETEROPLASMY IN MITOCHONDRIAL DNA
WO2021085425A1 (ja) * 2019-10-31 2021-05-06 義知 本田 血管老化予測方法、疾患リスク予測方法、血管老化予測用バイオマーカー、疾患用バイオマーカー、測定キット、及び、診断装置
CN112972681B (zh) * 2021-01-27 2022-06-07 西安交通大学 Mt-nd6作为新靶点在代谢综合征诊断和治疗药物中的应用
RU2760539C1 (ru) * 2021-02-07 2021-11-26 Федеральное государственное бюджетное образовательное учреждение высшего образования "Пензенский государственный университет" Способ скрининговой диагностики коронарного атеросклероза с помощью неинвазивного биомаркера-КА

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050089852A1 (en) * 2001-03-14 2005-04-28 Lee Shao C. Method and compositions for evaluating risk of developing type 2 diabetes in people of chinese descent
GB0209812D0 (en) * 2002-04-30 2002-06-05 Renovo Ltd Genetic testing
WO2008102924A1 (en) * 2007-02-23 2008-08-28 Pusan National University Industry-University Cooperation Foundation Microarray for detection of mitochondrial dna mutation and method for diagnosis of diabetes using the same

Also Published As

Publication number Publication date
EP2572002A4 (en) 2013-11-13
US20130136726A1 (en) 2013-05-30
EP2572002A1 (en) 2013-03-27
WO2011144818A1 (en) 2011-11-24

Similar Documents

Publication Publication Date Title
FI20100211A0 (fi) Menetelmä ateroskleroosialttiuden geneettiseksi diagnosoimiseksi
EP2673380A4 (en) ANALYSIS OF NUCLEIC ACIDS
CO6920291A2 (es) 3-pirmidin-4-il-oxazolidin-2-onas como inhibidores de la idhmutante
BR112014001453A2 (pt) aditivo catalizador e método de preparação do mesmo
DK2622532T3 (da) Fremgangsmåde til kollaborativ beregning
SMT201500233B (it) Metodi per rilevare anticorpi anti-farmaco
DK2598516T3 (da) Fremgangsmåde til proteinoprensning
BR112014007029A2 (pt) métodos aperfeiçoados de terapia gênica
GB201111460D0 (en) Point of sale system
EP2799538A4 (en) DIFFERENTIATION INDUCTION METHOD FOR PREVENTING TUMORIGENE TRANSFORMATION OF INDUCED PLURIPOTENT STEM CELLS (SPI)
FR2974202B1 (fr) Procede de multiplication de montgomery
AP2014008045A0 (en) Method of culturing algae
CU24148B1 (es) Intermedios de agomelatina y método de preparación de éstos
EP2771462A4 (en) PURIFICATION OF A NUCLEIC ACID
SMT201600071B (it) Derivato di acido pirrolidina-3-ilacetico
BR112014010316A2 (pt) método de carbonituração de peças em aço
FR2999175B1 (fr) Procede d'isolement de diamandoides
DK2591119T4 (da) Fermenteringsproces
FR2971388B1 (fr) Andaineur de pierres
FI20100388A0 (fi) Viljelymenetelmä
FI9035U1 (fi) Kouralana
CO6940378A2 (es) Diagnóstico de entamoeba histolylica
FI20100028A0 (fi) Uudenlainen rakeistusmenetelmä
FI9893U1 (fi) Järjestelmä työkelpoisuuden varmistamiseksi
UA22498S (uk) Комплект збірної лопати для прибирання снігу

Legal Events

Date Code Title Description
FD Application lapsed